Details

Introduction. <p><b>Section 1 Investigations.</b></p> <p>1 Routine cerebrospinal fluid (CSF) analysis.</p> <p>2 Use of imaging in cerebrovascular disease.</p> <p>3 Use of imaging in multiple sclerosis.</p> <p>4 Neurophysiological tests and neuroimaging procedures in non-acute headache.</p> <p>5 Use of anti-interferon beta antibody measurements in multiple sclerosis.</p> <p>6 Use of antibody testing in nervous system disorders.</p> <p>7 Use of skin biopsy in the diagnosis of small fibre neuropathy.</p> <p>8 Assessment of neuropathic pain.</p> <p><b>Section 2 Major Neurological Diseases.</b></p> <p>9 Ischaemic stroke and transient ischaemic attack.</p> <p>10 Drug treatment of migraine.</p> <p>11 Cluster headache and other trigemino-autonomic cephalgias.</p> <p>12 Diagnosis and treatment of primary (idiopathic) dystonia.</p> <p>13 Mild traumatic brain injury.</p> <p>14 Early (uncomplicated) Parkinson's disease.</p> <p>15 Late (complicated) Parkinson's disease.</p> <p>16 Alzheimer's disease.</p> <p><b>Section 3 Neuromuscular Diseases.</b></p> <p>17 Management of amyotrophic lateral sclerosis.</p> <p>18 Post-polio syndrome.</p> <p>19 Autoimmune neuromuscular transmission disorders.</p> <p>20 Chronic infl ammatory demyelinating polyradiculoneuropathy.</p> <p>21 Multifocal motor neuropathy.</p> <p>22 Paraproteinaemic demyelinating neuropathies.</p> <p>23 Limb girdle muscular dystrophies.</p> <p><b>Section 4 Infections.</b></p> <p>24 Neurological complications of HIV infection.</p> <p>25 Viral meningo-encephalitis.</p> <p><b>Section 5 Neurological Problems.</b></p> <p>26 Treatment of neuropathic pain.</p> <p>27 Acute relapses of multiple sclerosis.</p> <p>28 Status epilepticus.</p> <p>29 Alcohol-related seizures.</p> <p>30 Brain metastases.</p> <p>31 Paraneoplastic neurological syndromes.</p> <p>32 Nystagmus and oscillopsia.</p> <p>33 Orthostatic hypotension.</p> <p>34 Cerebral venous and sinus thrombosis.</p> <p>35 Cerebral vasculitis.</p> <p>36 Neurological problems in liver transplantation.</p> <p>37 Fatty acid mitochondrial disorders.</p> <p><b>Section 6 Sleep Disorders.</b></p> <p>38 Management of narcolepsy in adults.</p> <p>39 Sleep disorders in neurodegenerative disorders and stroke.</p> <p><b>Section 7 Rehabilitation.</b></p> <p>40 Cognitive rehabilitation.</p> <p>Index.</p>

<p>“Well written, easy to read, and highly educational, this book is a very nice addition to a neurologist's professional library.”  (<i>Doody’s</i>, 2 November 2012)</p> <p> </p>

Nils Erik Gilhus, MD, University of Bergen, Norway <p>Michael Brainin, MD, Danube University Krems, Austria</p> <p>Michael Barnes, MD FRCP, University of Newcastle, UK</p>

<b>Evidence-based, peer reviewed, best practice management guidelines for neurologists</b> <p>Diagnosis is only part of the puzzle. Effective treatment is what your patients really want. The European Federation of Neurological Societies has been publishing management guidelines in the <i>European Journal of Neurology</i> for many years. Developed by a consensus approach, using graded evidence, and then fully peer reviewed, these guidelines provide gold-standard, best-practice guidance to the treatment of neurological disorders. They help bridge the gap between what is done and what should be done for patients with neurological disorders.</p> <p>The basic guidelines have been expanded with 'Recommendations' based on strong evidence and 'Good Practice Points' where only weaker evidence is available. The Guidelines in this volume cover:</p> <ul> <li>Investigation</li> <li>Major neurological diseases</li> <li>Neuromuscular diseases</li> <li>Infections</li> <li>Neurological problems</li> <li>Sleep disorders</li> <li>Rehabilitation</li> </ul> <p>The <i>European Handbook of Neurological Management</i> provides a thoroughly rounded and grounded approach to best-practice neurological management using evidence-based principles.</p>

GB